Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ImmunoGen reports positive preclinical data for TAP, intention to speed up development

Nov. 19, 1999

AnorMED's platinum-based cancer treatment enters phase I clinical trials

Nov. 19, 1999

AACR-NCI-EORTC meeting highlights: phase I data reported for Lilly cryptophycin analogue

Nov. 19, 1999

Tumor regressions, good safety reported for CCI-779 at international conference

Nov. 19, 1999

Takeda presents new series for androgen- or estrogen-dependent disorders

Nov. 19, 1999

Results of Aptosyn trial show inhibition of rise in PSA levels in prostate cancer patients

Nov. 19, 1999

Ribozyme and Chiron initiate phase I/II studies of Angiozyme

Nov. 18, 1999

Somatostatin receptor ligands synthesized and tested at Takeda

Nov. 18, 1999

ImmunoGen options antibody from Duke and Johns Hopkins

Nov. 18, 1999

RPR/INGN-201 + radiotherapy provides supraadditive effects in prostate cancer xenograft models

Nov. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...